Motevalli, M. H., S. Taheri, F. Peiravian, and N. Yousefi. “Cost-Effectiveness of Sorafenib for Metastatic Renal Cell Carcinoma: A Systematic Review”. International Pharmacy Acta, vol. 2, no. 1, Dec. 2019, pp. 2e10:1-6, doi:10.22037/ipa.v2i1.24856.